Diagnostic Approach for Elevated Kappa and Lambda Light Chains

Initial Evaluation

The American College of Physicians recommends immediately assessing renal function and calculating the kappa:lambda ratio to distinguish between polyclonal elevation and monoclonal disease when both kappa and lambda light chains are elevated 1
A normal kappa:lambda ratio is 0.26-1.65, and a ratio within this range with both chains elevated strongly suggests polyclonal elevation from chronic kidney disease, inflammation, or infection 1, 2
In patients with severe renal impairment, the normal ratio expands to 0.34-3.10, making both chains appear elevated 1, 2
An abnormal ratio (>1.65 or <0.26) indicates monoclonal disease requiring immediate hematologic workup 1, 2

Essential laboratory studies include serum protein electrophoresis, serum immunofixation electrophoresis, 24-hour urine collection with urine protein electrophoresis and immunofixation, complete blood count, calcium, albumin, LDH, and beta-2 microglobulin 1, 2, 3
Serum protein electrophoresis is a quantitative and inexpensive screening test, while serum immunofixation electrophoresis is more sensitive for detecting monoclonal proteins 2

Primary considerations for a normal kappa:lambda ratio include non-malignant causes such as chronic kidney disease, inflammatory/autoimmune conditions, and reactive plasmacytosis from infections 1
A ratio outside the normal range requires immediate bone marrow evaluation and imaging to rule out monoclonal gammopathy of undetermined significance, multiple myeloma, or other plasma cell disorders 3, 1

The International Myeloma Society recommends diagnostic criteria for multiple myeloma, including an abnormal free light chain ratio, clonal bone marrow plasma cells, and myeloma-defining biomarkers or end-organ damage 1, 4
Light chain cast nephropathy is highly suspected when free light chains are >150 mg/dL, urine M-spike is >200 mg/day, and albuminuria is <10% 2, 4, 5

Discontinue all nephrotoxic medications and consider bortezomib/dexamethasone for light chain cast nephropathy 2, 5
Supportive measures include aggressive hydration, urine alkalinization, and correction of hypercalcemia 2, 4, 5

Use consistent methodology, including the same free light chain assay, to monitor response to treatment 1, 4
Assess response after one cycle, then every other cycle, and monitor all measurable parameters, including serum protein electrophoresis, serum immunofixation electrophoresis, 24-hour urine collection, and free light chains 2, 4